The effect of glioblastoma heterogeneity on survival stratification: a multimodal MR imaging texture analysis

Background Quantitative evaluation of the effect of glioblastoma (GBM) heterogeneity on survival stratification would be critical for the diagnosis, treatment decision, and follow-up management. Purpose To evaluate the effect of GBM heterogeneity on survival stratification, using texture analysis on multimodal magnetic resonance (MR) imaging. Material and Methods A total of 119 GBM patients (65 in long-term and 54 in short-term survival group, separated by overall survival of 12 months) were selected from the Cancer Genome Atlas, who underwent the T1-weighted (T1W) contrast-enhanced (CE), T1W, T2-weighted (T2W), and FLAIR sequences. For each sequence, the co-occurrence matrix, run-length matrix, and histogram features were extracted to reflect GBM heterogeneity on different scale. The recursive feature elimination based support vector machine was adopted to find an optimal subset. Then the stratification performance of four MR sequences was evaluated, both alone and in combination. Results When each sequence used alone, the T1W-CE sequence performed best, with an area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity of 0.7915, 80.67%, 78.45%, and 83.33%, respectively. When the four sequences combined, the stratification performance was basically equal to that of T1W-CE sequence. In the optimal subset of features extracted from multimodality, those from the T2W sequence weighted the most. Conclusion All the four sequences could reflect heterogeneous distribution of GBM and thereby affect the survival stratification, especially T1W-CE and T2W sequences. However, the stratification performance using only the T1W-CE sequence can be preserved with omission of other three sequences, when investigating the effect of GBM heterogeneity on survival stratification.

[1]  K. Yeom,et al.  Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches , 2017, American Journal of Neuroradiology.

[2]  Yang Liu,et al.  Relationship between Glioblastoma Heterogeneity and Survival Time: An MR Imaging Texture Analysis , 2017, American Journal of Neuroradiology.

[3]  S. Bakas,et al.  Advanced magnetic resonance imaging in glioblastoma: a review. , 2017, Chinese clinical oncology.

[4]  V. Pérez-García,et al.  Influence of gray level and space discretization on brain tumor heterogeneity measures obtained from magnetic resonance images , 2016, Comput. Biol. Medicine.

[5]  J. Borrás,et al.  Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. , 2016, The British journal of radiology.

[6]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[7]  Steven N. Kalkanis,et al.  The role of imaging in the management of adults with diffuse low grade glioma , 2015, Journal of Neuro-Oncology.

[8]  Steven D Chang,et al.  Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities , 2015, Science Translational Medicine.

[9]  Theodoros N. Arvanitis,et al.  Three‐dimensional textural features of conventional MRI improve diagnostic classification of childhood brain tumours , 2015, NMR in biomedicine.

[10]  Yemi Kim,et al.  Intratumoral metabolic heterogeneity predicts invasive components in breast ductal carcinoma in situ , 2015, European Radiology.

[11]  P. Wen,et al.  Glioma in 2014: Unravelling tumour heterogeneity—implications for therapy , 2015, Nature Reviews Clinical Oncology.

[12]  N. Just,et al.  Improving tumour heterogeneity MRI assessment with histograms , 2014, British Journal of Cancer.

[13]  Maciej A Mazurowski,et al.  A fully automatic extraction of magnetic resonance image features in glioblastoma patients. , 2014, Medical physics.

[14]  J. Seoane,et al.  Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature , 2014, Cancers.

[15]  Mark J. Ratain,et al.  Tumour heterogeneity in the clinic , 2013, Nature.

[16]  Karl Schaller,et al.  Long-term survival of patients with glioblastoma multiforme (GBM) , 2013, Journal of Clinical Neuroscience.

[17]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[18]  M. Hatt,et al.  Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.

[19]  Chih-Jen Lin,et al.  LIBSVM: A library for support vector machines , 2011, TIST.

[20]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[21]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[22]  Christos Davatzikos,et al.  Classification of brain tumor type and grade using MRI texture and shape in a machine learning scheme , 2009, Magnetic resonance in medicine.

[23]  Nathalie Boddaert,et al.  MRI Findings in 77 Children with Non-Syndromic Autistic Disorder , 2009, PloS one.

[24]  Alain Rakotomamonjy,et al.  Variable Selection Using SVM-based Criteria , 2003, J. Mach. Learn. Res..

[25]  Xiaoou Tang,et al.  Texture information in run-length matrices , 1998, IEEE Trans. Image Process..

[26]  Jill S Barnholtz-Sloan,et al.  Epidemiology of gliomas. , 2015, Cancer treatment and research.

[27]  L. Schad,et al.  MR image texture analysis--an approach to tissue characterization. , 1993, Magnetic resonance imaging.